Search research articles
Contact Us
Filters
Showing results (191-200 of 275) with videos related to
Page
of 28
Sort By:
Circulation. Genomic and Precision Medicine
|
August 28, 2020
Moving Genomics to Routine Care: An Initial Pilot in Acute Cardiovascular Disease
Zahra Aryan, Attila Szanto, Angeliki Pantazi, et al.
Circulation
|
November 17, 2020
Digital Care Transformation: Interim Report From the First 5000 Patients Enrolled in a Remote Algorithm-Based Cardiovascular Risk Management Program to Improve Lipid and Hypertension Control
Benjamin M Scirica, Christopher P Cannon, Naomi D L Fisher, et al.
Circulation. Genomic and Precision Medicine
|
December 14, 2022
Efficacy and Safety of ARRY-371797 in <i>LMNA</i>-Related Dilated Cardiomyopathy: A Phase 2 Study
Calum A MacRae, Matthew R G Taylor, Luisa Mestroni, et al.
Biorxiv : the Preprint Server for Biology
|
December 9, 2024
Suppression of cyclooxygenase-2 predisposes to heart failure with preserved ejection fraction
Emanuela Ricciotti, Philip G Haines, Manu Beerens, et al.
Journal of the American College of Cardiology
|
March 16, 2005
Adenosine monophosphate-activated protein kinase disease mimicks hypertrophic cardiomyopathy and Wolff-Parkinson-White syndrome: natural history
Ross T Murphy, Jens Mogensen, Kate McGarry, et al.
Developmental Cell
|
December 5, 2006
Klf2 is an essential regulator of vascular hemodynamic forces in vivo
John S Lee, Qing Yu, Jordan T Shin, et al.
Development (Cambridge, England)
|
December 20, 2013
Differential activation of natriuretic peptide receptors modulates cardiomyocyte proliferation during development
Jason R Becker, Sneha Chatterjee, Tamara Y Robinson, et al.
HGG Advances
|
May 23, 2022
Stx4 is required to regulate cardiomyocyte Ca<sup>2+</sup> handling during vertebrate cardiac development
Eliyahu Perl, Padmapriyadarshini Ravisankar, Manu E Beerens, et al.
Circulation. Heart Failure
|
July 9, 2024
REALM-DCM: A Phase 3, Multinational, Randomized, Placebo-Controlled Trial of ARRY-371797 in Patients With Symptomatic <i>LMNA</i>-Related Dilated Cardiomyopathy
Pablo Garcia-Pavia, Jose Fernando Rodriguez Palomares, Gianfranco Sinagra, et al.
Circulation. Cardiovascular Genetics
|
October 15, 2017
A Comparison of Whole Genome Sequencing to Multigene Panel Testing in Hypertrophic Cardiomyopathy Patients
Allison L Cirino, Neal K Lakdawala, Barbara McDonough, et al.
Page
of 28
Search research articles
Search
Showing results (191-200 of 275) with videos related to
Sort By:
Page
of 28
Circulation. Genomic and Precision Medicine
|
August 28, 2020
Moving Genomics to Routine Care: An Initial Pilot in Acute Cardiovascular Disease
Zahra Aryan, Attila Szanto, Angeliki Pantazi, et al.
Circulation
|
November 17, 2020
Digital Care Transformation: Interim Report From the First 5000 Patients Enrolled in a Remote Algorithm-Based Cardiovascular Risk Management Program to Improve Lipid and Hypertension Control
Benjamin M Scirica, Christopher P Cannon, Naomi D L Fisher, et al.
Circulation. Genomic and Precision Medicine
|
December 14, 2022
Efficacy and Safety of ARRY-371797 in <i>LMNA</i>-Related Dilated Cardiomyopathy: A Phase 2 Study
Calum A MacRae, Matthew R G Taylor, Luisa Mestroni, et al.
Biorxiv : the Preprint Server for Biology
|
December 9, 2024
Suppression of cyclooxygenase-2 predisposes to heart failure with preserved ejection fraction
Emanuela Ricciotti, Philip G Haines, Manu Beerens, et al.
Journal of the American College of Cardiology
|
March 16, 2005
Adenosine monophosphate-activated protein kinase disease mimicks hypertrophic cardiomyopathy and Wolff-Parkinson-White syndrome: natural history
Ross T Murphy, Jens Mogensen, Kate McGarry, et al.
Developmental Cell
|
December 5, 2006
Klf2 is an essential regulator of vascular hemodynamic forces in vivo
John S Lee, Qing Yu, Jordan T Shin, et al.
Development (Cambridge, England)
|
December 20, 2013
Differential activation of natriuretic peptide receptors modulates cardiomyocyte proliferation during development
Jason R Becker, Sneha Chatterjee, Tamara Y Robinson, et al.
HGG Advances
|
May 23, 2022
Stx4 is required to regulate cardiomyocyte Ca<sup>2+</sup> handling during vertebrate cardiac development
Eliyahu Perl, Padmapriyadarshini Ravisankar, Manu E Beerens, et al.
Circulation. Heart Failure
|
July 9, 2024
REALM-DCM: A Phase 3, Multinational, Randomized, Placebo-Controlled Trial of ARRY-371797 in Patients With Symptomatic <i>LMNA</i>-Related Dilated Cardiomyopathy
Pablo Garcia-Pavia, Jose Fernando Rodriguez Palomares, Gianfranco Sinagra, et al.
Circulation. Cardiovascular Genetics
|
October 15, 2017
A Comparison of Whole Genome Sequencing to Multigene Panel Testing in Hypertrophic Cardiomyopathy Patients
Allison L Cirino, Neal K Lakdawala, Barbara McDonough, et al.
Page
of 28